Down More Than 50% From Its High, Is Rocket Lab Stock a Good Buy Right Now?

Rocket Lab shares are down more than 50% from their 52-week high of $151, with the decline beginning around June as SpaceX went public and investors focused on delays to Rocket Lab’s larger Neutron rocket. The company generated nearly $770 million in trailing-12-month revenue but incurred losses exceeding $165 million; its Electron rocket has completed 97 successful launches, while Neutron is designed to carry 13,000 kg to low Earth orbit versus Electron’s capacity of up to 300 kg. The article presents a successful Neutron launch as a potential catalyst, while noting the anticipated launch later this year may be delayed; shares are up 6% year to date.

Analysis

The drawdown does not by itself establish mispricing: RKLB equity is increasingly a claim on converting Neutron development into a repeatable, economically attractive service. Another delay would extend development spending while leaving the business more dependent on its smaller-launch offering; that can pressure both cash expectations and the valuation multiple, with financing/dilution risk to verify rather than assume. A first successful launch would reduce technical risk, but would not prove customer demand, cadence, or margins. Look for follow-on bookings, payload utilization, launch frequency, and cash-burn trends.

SpaceX’s scale and capital access could constrain launch pricing and steer some customers toward rideshare, particularly for missions flexible on timing. Dedicated small-launch demand may still support Electron, but that niche should not be valued as proof of Neutron economics. Near term, attention and positioning can drive sharp reversals; over 1–3 months, company schedule updates and contract evidence matter more than the prior high. Over 6–18 months, cadence, unit economics, and funding needs determine whether the growth story compounds. The cautious view is falsified by a verified Neutron milestone followed by credible repeat-launch plans, commercial demand, and improving cash burn without reliance on new equity. A schedule slip or weaker cash position would reinforce it.

Key Decisions for Investors

• Do not treat the percentage decline from the high as a valuation signal. Keep RKLB on a catalyst watch until management provides a credible schedule and investors can assess cash runway and commercial commitments.
• If taking exposure ahead of a milestone, keep it small and define the maximum loss; avoid adding merely on a successful first launch. Scale only after evidence of follow-on demand and a repeatable cadence. Check option pricing and liquidity before considering any defined-risk options structure.
• Reassess or reduce exposure if the company pushes its latest stated schedule again, cash burn worsens without corresponding bookings, or financing needs become more likely. Do not short solely on a delay: milestone headlines create substantial gap risk.